Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.43 |
| ▸ | LDHA | P00338 | 1/20 | 0.42 |
| ▸ | CDK1 | P06493 | 1/20 | 0.41 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | VEGFA | P15692 | 2/20 | 0.40 |
| ▸ | SELP | P16109 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4795989 | 1.00 | AKT1 (0.43) | AKT1LDHACDK1CCNB1EPHX2 | |
| SCHEMBL15435982 | 1.00 | AKT1 (0.43) | AKT1LDHACDK1CCNB1EPHX2 | |
| SCHEMBL15436002 | 1.00 | AKT1 (0.43) | AKT1LDHACDK1CCNB1EPHX2 | |
| SCHEMBL10767543 | 1.00 | AKT1 (0.43) | AKT1LDHACDK1CCNB1EPHX2 | |
| SCHEMBL3025384 | 1.00 | AKT1 (0.43) | AKT1LDHACDK1CCNB1EPHX2 | |
| SCHEMBL1427803 | 0.95 | CETP (0.43) | LDHA | |
| SCHEMBL717379 | 0.94 | LDHA (0.41) | AKT1LDHACDK1CCNB1EPHX2 | |
| SCHEMBL744429 | 0.94 | AKT1 (0.42) | AKT1LDHACDK1CCNB1EPHX2 | |
| SCHEMBL5677688 | 0.94 | VEGFA (0.42) | AKT1LDHAVEGFA | |
| SCHEMBL15435989 | 0.92 | AKT1 (0.42) | AKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230355506-A1 | ACTIVE INGREDIENT COMPLEX FOR COSMETIC PREPARATIONS | LA PRAIRIE GROUP AG (CH) | 2023-11-09 | — | — | US | disclosed |
| US-20230355507-A1 | USE OF CAVIAR EXTRACTS | LA PRAIRIE GROUP AG (CH) | 2023-11-09 | — | — | US | disclosed |
| EP-4272724-A1 | SUBSTANCE COMBINATION FOR COSMETIC PREPARATIONS | La Prairie Group AG (CH) | 2023-11-08 | — | — | EP | disclosed |
| EP-4272725-A1 | USE OF CAVIAR EXTRACTS | La Prairie Group AG (CH) | 2023-11-08 | — | — | EP | disclosed |
| CN-116999377-A | Use of caviar extract | 拉普雷集团股份有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-116999376-A | Active substance combinations for cosmetic preparations | 拉普雷集团股份有限公司 | 2023-11-07 | — | — | CN | disclosed |
| US-20210283045-A1 | COSMETIC OR DERMATOLOGICAL PREPARATION CONTAINING A FISH EGG EXTRACT | LA PRAIRIE GROUP AG (CH) | 2021-09-16 | — | — | US | disclosed |
| US-10869817-B2 | Antiperspirant stick compositions | Henkel IP & Holding GmbH | 2020-12-22 | — | — | US | disclosed |
| US-10835483-B2 | Antiperspirant stick compositions | Henkel IP & Holding GmbH | 2020-11-17 | — | — | US | disclosed |
| US-10821068-B2 | Antiperspirant stick compositions | Henkel IP & Holding GmbH (DE) | 2020-11-03 | — | — | US | disclosed |
| US-20090047226-A1 | Quick-drying cosmetic emulsions for roll-on application | HENKEL AG & C. KGAA (DE) | 2009-02-19 | — | — | US | disclosed |
| US-20090010864-A1 | Low residue deodorant or antiperspirant stick based on an ethanol-containing oil-in-water dispersion/emulsion | HENKEL AG & CO. KGAA (DE) | 2009-01-08 | — | — | US | disclosed |
| US-20080241089-A1 | LOW-RESIDUE DEODORANT OR ANTIPERSPIRANT STICK BASED ON AN OIL-IN-WATER DISPERSION/EMULSION | HENKEL AG & CO. KGAA (DE) | 2008-10-02 | — | — | US | disclosed |
| EP-1893301-A1 | LOW-RESIDUE DEODORANT OR ANTIPERSPIRANT STICK BASED ON AN ETHANOL-CONTAINING OIL-IN-WATER DISPERSION/EMULSION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-03-05 | — | — | EP | disclosed |
| EP-1888179-A1 | LOW-RESIDUE DEODORANT OR ANTIPERSPIRANT STICK BASED ON AN OIL-IN-WATER DISPERSION/EMULSION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-02-20 | — | — | EP | disclosed |
| US-20070148437-A1 | Thermosensitive, biocompatible polymer carriers with changeable physical structure for therapy, diagnostics and analytics | MAGNAMEDICS GMBH (DE) | 2007-06-28 | — | — | US | disclosed |
| EP-1776878-A2 | Smoking articles and smokable filler material therefor | British American Tobacco (Investments) Limited (GB) | 2007-04-25 | — | — | EP | disclosed |
| WO-2006136330-A1 | LOW-RESIDUE DEODORANT OR ANTIPERSPIRANT STICK BASED ON AN ETHANOL-CONTAINING OIL-IN-WATER DISPERSION/EMULSION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-28 | — | — | WO | disclosed |
| WO-2006119981-A1 | LOW-RESIDUE DEODORANT OR ANTIPERSPIRANT STICK BASED ON AN OIL-IN-WATER DISPERSION/EMULSION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-11-16 | — | — | WO | disclosed |
| US-20050175702-A1 | Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis and therapy | MAGNAMEDICS GMBH (DE) | 2005-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355506-A1 | ACTIVE INGREDIENT COMPLEX FOR COSMETIC PREPARATIONS | MANBA, MAN2B1, MAN2A1 | AKT1 1682/4885LDHA 2389/4885CDK1 4484/4885 |
| US-20210283045-A1 | COSMETIC OR DERMATOLOGICAL PREPARATION CONTAINING A FISH EGG EXTRACT | TYR, CUTA, LAGE3 | AKT1 3967/4885LDHA 4016/4885CDK1 1684/4885 |
| US-20090047226-A1 | Quick-drying cosmetic emulsions for roll-on application | CUTA, UGCG, MGLL | AKT1 1387/4885LDHA 1184/4885CDK1 3333/4885 |
| US-20230355507-A1 | USE OF CAVIAR EXTRACTS | VIM, VCAM1, COL14A1 | AKT1 1794/4885LDHA 3296/4885CDK1 2096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.